Literature DB >> 21551026

Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease.

Maria V Irazabal1, John Huston, Vickie Kubly, Sandro Rossetti, Jamie L Sundsbak, Marie C Hogan, Peter C Harris, Robert D Brown, Vicente E Torres.   

Abstract

BACKGROUND AND OBJECTIVES: Autosomal dominant polycystic kidney disease (ADPKD) patients have an increased risk for intracranial aneurysms (IAs). The importance of screening for unruptured IAs (UIAs) depends on their risks for growth and rupture. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: ADPKD patients with UIAs found by presymptomatic screening with magnetic resonance angiography (MRA) during 1989 to 2009 were followed initially at 6 months and annually, and less frequently after demonstration of stability.
RESULTS: Forty-five saccular aneurysms were detected in 38 patients from 36 families. Most were small (median diameter 3.5 mm) and in the anterior circulation (84%). Median age at diagnosis was 49 years. During cumulative imaging follow-up of 243 years, one de novo UIA was detected and increased in size from 2 to 4.4 mm over 144 months and two UIAs grew from 4.5 to 5.9 mm and 4.7 to 6.2 mm after 69 and 184 months, respectively. Seven patients did not have imaging follow-up. No change was detected in the remaining 28 patients. During cumulative clinical follow-up of 316 years, no aneurysm ruptured. Five patients died from unrelated causes and two were lost to follow-up after 8 and 120 months. Three patients underwent surgical clipping.
CONCLUSIONS: Most UIAs detected by presymptomatic screening in ADPKD patients are small and in the anterior circulation. Growth and rupture risks are not higher than those of UIAs in the general population. These data support very selective screening for UIAs in ADPKD patients, and widespread screening is not indicated.

Entities:  

Mesh:

Year:  2011        PMID: 21551026      PMCID: PMC3109922          DOI: 10.2215/CJN.09731110

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

Review 1.  Management of cerebral aneurysms in autosomal dominant polycystic kidney disease.

Authors:  Yves Pirson; Dominique Chauveau; Vicente Torres
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study.

Authors:  A S E Bor; G J E Rinkel; J Adami; H Koffijberg; A Ekbom; E Buskens; P Blomqvist; F Granath
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

3.  Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

Authors:  Sandro Rossetti; Dominique Chauveau; Vickie Kubly; Jeffrey M Slezak; Anand K Saggar-Malik; York Pei; Albert C M Ong; Fiona Stewart; Michael L Watson; Erik J Bergstralh; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

Review 4.  Treatment of unruptured intracranial aneurysms: surgery, coiling, or nothing?

Authors:  Joseph D Burns; Robert D Brown
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

5.  Unruptured intracranial aneurysms: incidence of rupture and risk factors.

Authors:  Toshihiro Ishibashi; Yuichi Murayama; Mitsuyoshi Urashima; Takayuki Saguchi; Masaki Ebara; Hideki Arakawa; Koreaki Irie; Hiroyuki Takao; Toshiaki Abe
Journal:  Stroke       Date:  2008-10-09       Impact factor: 7.914

6.  Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection.

Authors:  Robert D Brown; John Huston; Richard Hornung; Tatiana Foroud; David F Kallmes; Dawn Kleindorfer; Irene Meissner; Daniel Woo; Laura Sauerbeck; Joseph Broderick
Journal:  J Neurosurg       Date:  2008-06       Impact factor: 5.115

7.  Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Authors:  Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul A Thompson; J Philip Miller; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

Review 8.  Natural history, epidemiology and screening of unruptured intracranial aneurysms.

Authors:  G J E Rinkel
Journal:  J Neuroradiol       Date:  2008-02-01       Impact factor: 3.447

9.  Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors.

Authors:  Joseph D Burns; John Huston; Kennith F Layton; David G Piepgras; Robert D Brown
Journal:  Stroke       Date:  2008-11-20       Impact factor: 7.914

10.  Endovascular treatment of unruptured intracranial aneurysms with Guglielmi detachable coils: short- and long-term results of a single-centre series.

Authors:  Harald Standhardt; Hans Boecher-Schwarz; Andreas Gruber; Thomas Benesch; Engelbert Knosp; Gerhard Bavinzski
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  36 in total

1.  Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere.

Authors:  M Niemczyk
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

2.  Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Irina M Sanchis; Shehbaz Shukoor; Maria V Irazabal; Charles D Madsen; Fouad T Chebib; Marie C Hogan; Ziad El-Zoghby; Peter C Harris; John Huston; Robert D Brown; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-30       Impact factor: 8.237

Review 3.  An approach to cystic kidney diseases: the clinician's view.

Authors:  Christine E Kurschat; Roman-Ulrich Müller; Mareike Franke; David Maintz; Bernhard Schermer; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

4.  Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrien Flahault; Dominique Joly
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 8.237

Review 5.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

6.  On the role of screening for intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  J P Klein
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

7.  Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches.

Authors:  D Andrew Wilkinson; Michael Heung; Amrit Deol; Neeraj Chaudhary; Joseph J Gemmete; B Gregory Thompson; Aditya S Pandey
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

8.  Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Pamela Mettler; Kim Mc Fann; Oleksandra Tkachenko; Xiang-Dong Yan; Robert W Schrier
Journal:  Am J Nephrol       Date:  2012-10-04       Impact factor: 3.754

Review 9.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

10.  Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  M Niemczyk; M Gradzik; S Niemczyk; M Bujko; M Gołębiowski; L Pączek
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.